(CNN) — A third dose of the Pfizer/BioNTech Covid-19 vaccine can “strongly” boost protection against the Delta variant — beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday.
The data posted online, which are expected to be discussed in a company earnings call on Wednesday morning, suggest that antibody levels against the Delta variant in people ages 18 to 55 who receive a third dose of vaccine are greater than five-fold than following a second dose.READ MORE: Flo Rida, Dru Hill Among Orioles Birdland Summer Music Series Lineup
Among people ages 65 to 85, the Pfizer data suggest that antibody levels against the Delta variant after receiving the third dose of vaccine are greater than 11-fold than following a second dose.
There’s an “estimated potential for up to 100-fold increase in Delta neutralization post-dose three compared to pre-dose three,” researchers wrote in the Pfizer data slides.READ MORE: Harrison Calls For Clarification On State's Attorney's List Of 305 Baltimore Officers With Credibility Issues
The data have not yet been peer-reviewed or published.
The data also show that antibody levels are much higher after the third dose than a second dose against the original coronavirus variant and the Beta variant, first identified in South Africa.MORE NEWS: B&O Railroad Museum Offering Free Admission To Active Duty Military Personnel Through Labor Day
™ & © 2021 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.